Results 331 to 340 of about 1,168,781 (390)

Systemic evaluation of the effects of monomeric GLP-1R-based agonists on MASLD and its complications. [PDF]

Diabetol Metab Syndr
Cai Y, Xie S, Xu L, Chen J, Cai J.
europepmc   +1 more source

Extensive Arteriovenous Fistula Thrombosis With Glucagon-Like Peptide-1 Agonist. [PDF]

Cureus
Muneeb M, Choi E, Rodriguez C, Goyal K, Bhura Z, Hannoudi G.   +5 more
europepmc   +1 more source

Review: Special Issue: <i>Real-world evidence on the use of GLP1 receptor agonists</i>: Emerging concepts in obesity management: focus on glucagon receptor agonist combinations. [PDF]

Drugs Context
Anderson SL.
europepmc   +1 more source

Transforming Care: Implications of Glucagon Like Peptide-1 Receptor Agonists on Physical Therapist Practice.

Phys Ther
Mulcahy J, DeLaRosby A, Norwood T.
europepmc   +1 more source